0001962918-24-000002.txt : 20240104
0001962918-24-000002.hdr.sgml : 20240104
20240104180903
ACCESSION NUMBER: 0001962918-24-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240102
FILED AS OF DATE: 20240104
DATE AS OF CHANGE: 20240104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lin Shao-Lee
CENTRAL INDEX KEY: 0001725092
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41696
FILM NUMBER: 24513667
MAIL ADDRESS:
STREET 1: C/O ACELYRIN, INC.
STREET 2: 4149 LIBERTY CANYON RD.
CITY: AGOURA HILLS
STATE: CA
ZIP: 91301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELYRIN, Inc.
CENTRAL INDEX KEY: 0001962918
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 852406735
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4149 LIBERTY CANYON RD.
CITY: AGOURA HILLS
STATE: CA
ZIP: 91301
BUSINESS PHONE: 805-871-4300
MAIL ADDRESS:
STREET 1: 4149 LIBERTY CANYON RD.
CITY: AGOURA HILLS
STATE: CA
ZIP: 91301
4
1
wk-form4_1704409733.xml
FORM 4
X0508
4
2024-01-02
0
0001962918
ACELYRIN, Inc.
SLRN
0001725092
Lin Shao-Lee
C/O ACELYRIN, INC.
4149 LIBERTY CANYON RD.
AGOURA HILLS
CA
91301
1
1
0
0
Chief Executive Officer
0
Common Stock
2024-01-02
4
S
0
10691
7.407
D
1603036
D
Common Stock
487205
I
See footnote
Common Stock
677813
I
See footnote
Common Stock
354969
I
See footnote
Common Stock
349898
I
See footnote
Common Stock
5070
I
See footnote
The sale reported on this Form 4 was effected pursuant to the Issuer's policy requiring sell-to-cover to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain Restricted Stock Units, and does not represent a discretionary sale by the Reporting Person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices no more than $7.62 and no less than $7.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes 1,293 shares of Common Stock acquired pursuant to the Issuer's 2023 Employee Stock Purchase Plan ("ESPP"), for the purchase period of June 15, 2023 to December 14, 2023. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's Common Stock on December 14, 2023.
Shares held directly by Shao-Lee Lin 2020 Gift Trust Dtd 7/16/20, for which the Reporting Person's spouse serves as trustee.
Shares held directly by Shao-Lee Lin, Trustee of the Shao-Lee Lin Trust u/a/d September 23, 2005, for which the Reporting Person serves as trustee.
Shares held directly by Lin Family 2020 Gift Trust Dtd 7/16/20, for which the Reporting Person's spouse shares voting and investment power.
Shares held directly by Susie Jun 2020 Gift Trust dtd 7/16/20, for which the Reporting Person serves as trustee.
Shares held directly by Susie Jun, Trustee of the Susie Jun Trust U/A/D September 23, 2005, for which the Reporting Person's spouse serves as trustee.
/s/ Mina Kim, Attorney-in-fact
2024-01-04